Detalhe da pesquisa
1.
Pyrotinib plus capecitabine for patients with human epidermal growth factor receptor 2-positive breast cancer and brain metastases (PERMEATE): a multicentre, single-arm, two-cohort, phase 2 trial.
Lancet Oncol
; 23(3): 353-361, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35085506
2.
Study of Drug Resistance in Chemotherapy Induced by Extracellular Vesicles on a Microchip.
Anal Chem
; 94(48): 16919-16926, 2022 12 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36420757
3.
Synergistic effects of α-Mangostin and sorafenib in hepatocellular carcinoma: New insights into α-mangostin cytotoxicity.
Biochem Biophys Res Commun
; 558: 14-21, 2021 06 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33894673
4.
Preoperative prediction of pathologic grade of HCC on gadobenate dimeglumine-enhanced dynamic MRI.
Eur Radiol
; 31(10): 7584-7593, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33860826
5.
Efficacy of Oxaliplatin/5-Fluorouracil/Capecitabine-Cetuximab Combination Therapy and Its Effects on K-Ras Mutations in Advanced Colorectal Cancer.
Med Sci Monit
; 26: e919031, 2020 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32062671
6.
METTL3 facilitates tumor progression via an m6A-IGF2BP2-dependent mechanism in colorectal carcinoma.
Mol Cancer
; 18(1): 112, 2019 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-31230592
7.
Plasma cell-free DNA chromosomal instability analysis by low-pass whole-genome sequencing to monitor breast cancer relapse.
Breast Cancer Res Treat
; 178(1): 63-73, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31364001
8.
MicroRNA and LncRNA Expression Profiles in Human Estrogen Receptor Positive Breast Cancer.
Clin Lab
; 65(1)2019 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30775882
9.
Comparison of five models for end-stage liver disease in predicting the survival rate of patients with advanced hepatocellular carcinoma.
Tumour Biol
; 37(4): 5265-73, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26561464
10.
Alanine aminotransferase to hemoglobin ratio is an indicator for disease progression for hepatocellular carcinoma patients receiving transcatheter arterial chemoembolization.
Tumour Biol
; 37(3): 2951-9, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26411670
11.
Platelet-to-lymphocyte ratio acts as a prognostic factor for patients with advanced hepatocellular carcinoma.
Tumour Biol
; 36(4): 2263-9, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25409616
12.
Autophagic LC3B overexpression correlates with malignant progression and predicts a poor prognosis in hepatocellular carcinoma.
Tumour Biol
; 35(12): 12225-33, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25256671
13.
Neutrophil-to-lymphocyte ratio acts as a prognostic factor for patients with advanced hepatocellular carcinoma.
Tumour Biol
; 35(11): 11057-63, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25095975
14.
Prognosis value of mitotic kinase Aurora-A for primary duodenal adenocarcinoma.
Tumour Biol
; 35(9): 9361-70, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24943686
15.
Characterizing the Efficacy and Safety of Chemotherapy Plus Everolimus in HER2-Negative Metastatic Breast Cancer Harboring Altered PI3K/AKT/mTOR.
Discov Med
; 36(182): 527-537, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38531793
16.
Beclin 1 activation enhances chemosensitivity and predicts a favorable outcome for primary duodenal adenocarcinoma.
Tumour Biol
; 34(2): 713-22, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23225331
17.
An optimized antiviral modification strategy for prevention of hepatitis B reactivation in patients undergoing prophylactic lamivudine and chemotherapy: a pilot study.
Tumour Biol
; 34(2): 909-18, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23269606
18.
PFKFB2 is a favorable prognostic biomarker for colorectal cancer by suppressing metastasis and tumor glycolysis.
J Cancer Res Clin Oncol
; 149(12): 10737-10752, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37311985
19.
Individualize management for advanced breast cancer with pyrotinib-based anti-HER2 therapy: a case report.
Transl Breast Cancer Res
; 4: 25, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38751473
20.
Pyrotinib plus docetaxel as first-line treatment for HER2-positive metastatic breast cancer: the PANDORA phase II trial.
Nat Commun
; 14(1): 8314, 2023 Dec 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38097605